tiprankstipranks
pc:artcl

ARTCLINE GmbH

ARTCLINE GmbH is a biomedical company specializing in the development of innovative immune cell therapies for the treatment of septic shock, a critical condition with significant unmet medical needs. The company's proprietary ARTICE® therapy employs allogeneic immune cells from healthy donors to support and regenerate the impaired immune systems of patients, aiming to address immune dysfunction and improve patient outcomes. ARTCLINE is actively engaged in clinical trials to validate the efficacy of its therapy and prepare for market introduction.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$5M
Total Amount Raised$5M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$5M
Latest Funding Amount$5M
Latest Funding RoundConvertible Notes
Latest Funding RoundConvertible Notes
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 09, 2025
Convertible Notes
$5.00M

Related News and Analysis